“amgen” Archives

Entry Author Date Location
After Spinning Onyx into Gold, Coles Returns to Lead a CNS Startup 12/15/14 Boston
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
Immunotherapy Confidence (And Audience) Abundant At ASH T-Cell Talk 12/08/14 National
West Coast Biotech Roundup: Amgen, Ariosa, Avanir, Audentes & More 12/04/14 San Diego
Patient Deaths Move Amgen To Pull Drug From Stomach Cancer Trials 11/24/14 Seattle
With Gilead’s $125M Purchase, FDA Voucher Program Gains Momentum 11/19/14 San Francisco
As Rival Sputters, FibroGen Heads to Nasdaq Via $146M IPO 11/14/14 San Francisco
West Coast Biotech Roundup: Intarcia, Dendreon, Amgen, Doudna & More 11/13/14 San Francisco
As Huge Bills Loom, Immunotherapy Pioneer Dendreon Enters Bankruptcy 11/10/14 Seattle
East Coast Biotech Roundup: Intercept, Idera, Inotek, & More 11/07/14 Boston
Struggling Aegerion Diversifies With Fat Disease Drug 11/06/14 Boston
West Coast Biotech Roundup: Amgen, Inslee, Fibrogen, Receptos & More 10/30/14 Seattle
Opsona, And Pharma Backers, Await Day of Reckoning for Kidney Drug 10/29/14 National
Q&A: WA Gov. Inslee on Education, Life Sciences, Climate, R&D 10/24/14 Seattle
Cambia Grove Aims to Spur Healthcare Innovation in Seattle 10/24/14 Seattle
Organovo CEO: Closing IPO Window Could Spur More Reverse Mergers 10/24/14 Wisconsin
West Coast Biotech Roundup: Genentech, Sutro, Amgen, Regulus & More 10/23/14 San Francisco
New Atlas Startup Gets “Quartet” of Backers, $17M For Pain Drugs 10/23/14 Boston
Atara Bio Pays the Price for Delayed IPO, Sinks in Debut 10/16/14 San Francisco
What Seattle Needs (Part 2): Dealing With Amgen’s Upcoming Departure 10/07/14 Seattle
What Seattle Needs (Part 1): “Semi-Successful” Biotech Companies 10/06/14 Seattle
An Intriguing Program Takes on Tropical Diseases—But Not Ebola 09/10/14 National
West Coast Biotech Roundup: Mapp Bio, Calico, Alder, VentiRx & More 09/04/14 San Diego
West Coast Biotech Roundup: Onyx, Calico, Otonomy, Dendreon & More 08/14/14 San Francisco
With $310M and Public Investors Aboard, Is a Juno IPO Next? 08/05/14 Seattle
West Coast Biotech Roundup: Amgen Layoffs, Avalanche, Venter & More 07/31/14 Seattle
How a Little Serendipity Led Acceleron to a Crippling Blood Disease 07/17/14 Boston
Who Needs Biotech VCs, Anyway? 07/15/14 San Francisco
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
As Its Investors Reap Returns, venBio Aims for a Bigger Second Fund 06/10/14 San Francisco
Page 3 of 15 « previous page · next page »